Peter Held
Impact in
-
- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Blood Pressure and Hypertension Studies
- Cardiac pacing and defibrillation studies
- Renin-Angiotensin System Studies
- Cardiac electrophysiology and arrhythmias
-
- Hormonal Regulation and Hypertension
Papers in
-
- Venous Thromboembolism Diagnosis and Management 8
-
- Heart Failure Treatment and Management 13
- Antiplatelet Therapy and Cardiovascular Diseases 11
- Cardiovascular Function and Risk Factors 10
- Cardiac electrophysiology and arrhythmias 9
- Cardiac pacing and defibrillation studies 6
- Atrial Fibrillation Management and Outcomes 4
- Co-authors
- Salim YusufKarl SwedbergJohn J.V. McMurrayBertil OlofssonJan ÖstergrenEric L. MichelsonMarc A. PfefferChristopher B. Granger
- Journals
- The Lancet (5 papers)American Heart Journal (3 papers)Circulation (2 papers)European Heart Journal (2 papers)British Journal of Clinical Pharmacology (2 papers)
- Partner nations
- SwedenUnited StatesUnited Kingdom
In The Last Decade
Peter Held
37 papers receiving 9.1k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Cardiology and Cardiovascular Medicine 8.4k
- Endocrinology, Diabetes and Metabolism 2.1k
- Family Practice 191
- Internal Medicine 270
- Pulmonary and Respiratory Medicine 1.3k
Countries citing papers authored by Peter Held
This map shows the geographic impact of Peter Held's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Held with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Held more than expected).
Fields of papers citing papers by Peter Held
This network shows the impact of papers produced by Peter Held. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Held. The network helps show where Peter Held may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter Held, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 61 | |
| 2 | 2017 | 22 | |
| 3 | Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease Hit paper breakdown → | 2016 | 386 |
| 4 | 2016 | 38 | |
| 5 | 2016 | 8 | |
| 6 | CHARM IN-VESTIGATORS AND COMMITTEES. EFFECTS OF CANDESARTAN IN PATIENTS WITH CHRONIC HEART FAILURE AND REDUCED LEFT-VENTRICULAR SYSTOLIC FUNCTION TAKING ANGIOTENSIN-CONVERTING-ENZYME INHIBITORS: THE CHARM-ADDED TRIAL Hit paper breakdown → | 2003 | 794 |
| 7 | Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme Hit paper breakdown → | 2003 | 1333 |
| 8 | 2003 | 111 | |
| 9 | Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial Hit paper breakdown → | 2003 | 2033 |
| 10 | Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial Hit paper breakdown → | 2003 | 1115 |
| 11 | Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial Hit paper breakdown → | 2003 | 1791 |
| 12 | 1999 | 227 | |
| 13 | 1999 | 81 | |
| 14 | 1999 | 6 | |
| 15 | 1998 | 8 | |
| 16 | 1995 | 3 | |
| 17 | 1992 | 15 | |
| 18 | Effects of the Early Administration of Enalapril on Mortality in Patients with Acute Myocardial Infarction Hit paper breakdown → | 1992 | 676 |
| 19 | 1992 | 86 | |
| 20 | 1990 | 2 |
About Peter Held
Peter Held is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine, Family Practice, Surgery and Statistics, Probability and Uncertainty, having authored 37 papers that have together received 9.5k indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (13 papers), Antiplatelet Therapy and Cardiovascular Diseases (11 papers), Cardiovascular Function and Risk Factors (10 papers), Peripheral Artery Disease Management (10 papers), Cardiac electrophysiology and arrhythmias (9 papers), Venous Thromboembolism Diagnosis and Management (8 papers), Cardiac pacing and defibrillation studies (6 papers) and Atrial Fibrillation Management and Outcomes (4 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (8.4k citations), Endocrinology, Diabetes and Metabolism (2.1k citations), Family Practice (191 citations), Internal Medicine (270 citations) and Pulmonary and Respiratory Medicine (1.3k citations). Peter Held has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include Salim Yusuf, Karl Swedberg, John J.V. McMurray, Bertil Olofsson, Jan Östergren, Eric L. Michelson, Marc A. Pfeffer, Christopher B. Granger, C. B. Granger and Lars Rydén. Their work appears in journals such as The Lancet, American Heart Journal, Circulation, European Heart Journal and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.